Company: SMNR
Filing Date: 2025-06-11
Form Type: S-4/A
Source: 0001193125-25-139124
Chunk: 444

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-06-11
Form: S-4/A
Chunk 444
---
             (0.40 | ) |     | $ |          (0.50 | ) |

|                                                                                                                                                                                       | Consolidated Balance Sheet Data: |   |        As of 
 December 31, 
         2024 |   |     |   |        As of 
 December 31, 
         2023 |   |
|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|:---------------------------------|:--|-------------:|:--|:----|:--|-------------:|:--|
| Total current assets                                                                                                                                                                  |                                  | $ |       16,868 |   |     | $ |      209,440 |   |
| Cash and Investments held in trust                                                                                                                                                    |                                  |   |    9,021,005 |   |     |   |   50,477,963 |   |
| Total assets                                                                                                                                                                          |                                  |   |    9,037,873 |   |     |   |   50,687,403 |   |
| Total liabilities                                                                                                                                                                     |                                  |   |   10,434,584 |   |     |   |    8,491,480 |   |
| Class A ordinary shares subject to possible redemption 751,837 and 4,537,829 shares at redemption value of $12.00 and $11.12 per share as of December 31, 2024 and 2023, respectively |                                  |   |    9,021,005 |   |     |   |   50,477,963 |   |
| Total shareholders’ deficit                                                                                                                                                           |                                  |   |  (10,417,716 | ) |     |   |   (8,282,040 | ) |

269

SELECTED HISTORICAL FINANCIAL INFORMATION OF SEMNUR The following selected statements of operations data for the years ended December 31, 2024 and 2023 and the selected balance sheet data as of December 31, 2024 and 2023 have been derived from Semnur’s audited financial statements included elsewhere in this proxy statement/prospectus. The following selected statements of operations data for the three months ended March 31, 2025 and 2024 and the selected balance sheet data as of March 31, 2025 have been derived from Semnur’s unaudited financial statements included elsewhere in this proxy statement/prospectus. Semnur’s unaudited financial statements have been prepared on the same basis as the